Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Rizwan S. Akhtar, MD, PhD

Rizwan S. Akhtar, MD, PhD Physician

Assistant Professor of Neurology at the Pennsylvania Hospital

Dr. Akhtar is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties

Specialty:

  • Neurology

Programs & Centers:

Board Certification:

  • Neurology, 2011

Clinical Expertise:

  • Ataxia
  • Atypical Parkinsonism Syndromes
  • Corticobasal Syndrome (CBS)
  • Dementia with Lewy Bodies (DLB)
  • Dystonia
  • Essential Tremor
  • Hemifacial Spasm (HFS)
  • Huntington's Disease (HD)
  • Multiple System Atrophy (MSA)
  • Parkinson's Disease
  • Progressive Supranuclear Palsy (PSP)
  • Tourette's Syndrome (TS)

Description of Clinical Expertise

Movement disorders, including Parkinson's disease, atypical parkinsonism, dystonia, ataxia, blepharospasm, and essential tremor.

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School:
Residency: University of Alabama Hospital
Residency: Hospital of the University of Pennsylvania

Memberships

American Academy of Neurology, National American Neurological Association, National Movement Disorders Society, International Society for Neuroscience, International Society for Neuroscience, International

Hospital Affiliation

Dr. Akhtar is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Development of α-synuclein and amyloid-β biomarkers for Parkinson's disease and related neurodegenerative diseases.

Selected Publications:

Akhtar RS, Licata JP, Luk KC, Covell DJ, Trojanowski JQ: Epitope mapping of CSF auto-antibodies to α-synuclein. Movement Disorders : 2017.

Akhtar RS, Xie SX, Chen YJ, Rick J, Gross RG, Nasrallah IM, Van Deerlin VM, Trojanowski JQ, Chen-Plotkin AS, Hurtig HI, Siderowf AD, Dubroff JG: Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia. PLoS One 12 (5): 2017.

Covell DJ, Robinson JL, Akhtar RS, Grossman M, Weintraub D, Bucklin HM, Pitkin RM, Riddle D, Yousef A, Trojanowski JQ: Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson’s disease. Neuropathology and Applied Neurobiology : 2017.

Akhtar RS, Xie SX, Brennan L, Pontecorvo MJ, Hurtig HI, Trojanowski JQ, Weintraub D: Amyloid-β PET imaging of Alzheimer pathology in Parkinson disease dementia. Movement Disorders Clinical Practice 3 (4): 367-375,2016.

Akhtar RS, Luk KC, Trojanowski JQ: Auto-antibodies to α-synuclein are present in Parkinson Disease biofluids. Movement Disorders 30 (suppl 1): S28,2015.

Pigott K, Rick J, Xie SX, Hurtig HI, Chen-Plotkin AS, Duda JE, Morley JF, Chahine LM, Dahodwala N, Akhtar RS, Siderowf AD, Trojanowski JQ: Longitudinal study of normal cognition in Parkinson’s Disease. Neurology 85 (15): 1276-1282,2015.

Akhtar RS: New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications. Expert Review of Neurotherapeutics 12 (12): 1429-1438,2012.

Akhtar RS: Psychiatric manifestations of common neurologic disorders. Principles and Practice of Geriatric Psychiatry 2 ed : 735-744,2011.

Akhtar RS, Latham CB, Siniscalco D, Fuccio C: Immunohistochemical detection with quantum dots. Methods in Molecular Biology 374 : 11-28,2007.

Akhtar RS, Klocke BJ, Strasser A: Loss of BH3-only protein Bim inhibits apoptosis of hemopoietic cells in the fetal liver and male germ cells but not neuronal cells in bcl-x-deficient mice. Journal of Histochemistry and Cytochemistry 56 (10): 921-927,2008.

Akhtar RS: Regulation of neural stem cell death. Neural Development and Stem Cells 2 ed. : 97-122,2006.

Akhtar RS, Geng Y, Klocke BJ, Latham CB, Villunger A, Michalak EM, Strasser A, Carroll SL: BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death. The Journal of Neuroscience 26 (27): 7257-7264,2006.

Akhtar RS, Geng Y, Klocke BJ: Neural precursor cells possess multiple p53-dependent apoptotic pathways. Cell Death and Differentiation 13 (10): 1727-1739,2006.

Akhtar RS, Ness JM: Bcl-2 family regulation of neuronal development and neurodegeneration. Biochimica et Biophysica Acta 1644 (2-3): 189-203,2004.

Ness JM, Akhtar RS, Latham CB: Combined tyramide signal amplification and quantum dots for sensitive and photostable immunofluorescence detection. Journal of Histochemistry and Cytochemistry 51 (8): 981-987,2003.

View all publications

Academic Contact Info

330 South 9th St, Fourth Floor
Penn Neurological Institute

Philadelphia, PA 19107
Patient appointments: 800-789-7366 (PENN)